Detection of Colorectal Cancer and Advanced Adenoma by Liquid Biopsy (Decalib Study): The ddPCR Challenge
Open Access
- 5 June 2020
- Vol. 12 (6), 1482
- https://doi.org/10.3390/cancers12061482
Abstract
Background: In most countries, participation in colorectal cancer (CRC) screening programs with the immunological fecal occult blood test (iFOBT) is low. Mutations of RAS and BRAF occur early in colorectal carcinogenesis and “liquid biopsy” allows detection of mutated circulating tumor DNA (ctDNA). This prospective study aims to evaluate the performance of RAS and BRAF-mutated ctDNA in detecting CRC and advanced adenomas (AA). Methods: One hundred and thirty patients who underwent colonoscopy for suspicion of colorectal lesion were included and divided into four groups: 20 CRC, 39 AA, 31 non-advanced adenoma and/or hyperplastic polyp(s) (NAA) and 40 with no lesion. Mutated ctDNA was analyzed by droplet digital PCR. Results: ctDNA was detected in 45.0% of CRC, in 2.6% of AA and none of the NAA and “no-lesion” groups. All patients with stage II to IV mutated CRC had detectable ctDNA (n = 8/8). Among the mutated AA, only one patient had detectable ctDNA (4.3%), maybe due to limited technical sensitivity or to a low rate of ctDNA or even the absence ctDNA in plasma. Specificity and sensitivity of KRAS- and BRAF-mutated ctDNA for the detection of all CRC and AA were 100% and 16.9%, respectively. Conclusions: ctDNA had high sensitivity in detection of advanced mutated CRC but was unable to sensitively detect AA. ctDNA analysis was easy to perform and readily accepted by the population but requires combination with other circulating biomarkers before replacing iFOBT.Funding Information
- Ligue Contre le Cancer (NA)
This publication has 38 references indexed in Scilit:
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy NumberAnalytical Chemistry, 2011
- Quantitative and sensitive detection of rare mutations using droplet-based microfluidicsLab on a Chip, 2011
- Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancerGenes, Chromosomes and Cancer, 2011
- Circulating free tumor DNA and colorectal cancerGastroentérologie Clinique et Biologique, 2010
- Comparison of Guaiac-Based and Quantitative Immunochemical Fecal Occult Blood Testing in a Population at Average Risk Undergoing Colorectal Cancer ScreeningThe American Journal of Gastroenterology, 2010
- Detection and Monitoring of Cell‐Free DNA in Blood of Patients with Colorectal CancerAnnals of the New York Academy of Sciences, 2008
- Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancerCancer Letters, 2008
- Quantitative Analysis of Plasma DNA in Colorectal Cancer PatientsAnnals of the New York Academy of Sciences, 2006
- Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancerHistopathology, 2006
- Detection of free‐circulating tumor‐associated DNA in plasma of colorectal cancer patients and its association with prognosisInternational Journal of Cancer, 2002